[RGLS] YoY Annual Result on 31-Dec-2021 [#FY]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
10-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#FY]
Profit Trend
YoY- -82.19%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 0 0 0 10,006 6,832 72 72 -
PBT -30,036 -28,322 -27,807 -15,730 -18,591 -48,647 -72,102 -13.57%
Tax 1 1 1 -467 1 62 -197 -
NP -30,037 -28,323 -27,808 -15,263 -18,592 -48,709 -71,905 -13.53%
Tax Rate - - - - - - - -
Total Cost 30,037 28,323 27,808 25,269 25,424 48,781 71,977 -13.54%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 -152.54 -272.13 -67,651.39 -99,868.06 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.58 -1.86 -3.24 -4.36 -10.77 -55.87 -114.70 -51.02%
EPS Diluted -1.58 -1.86 -3.24 -4.36 -10.77 -55.87 -114.70 -51.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.